UCI-1
UCI-1
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-M-1537 | 1mg | 300.00 | + Add to cart |
|
| R-M-1537 | 5mg | 1200.00 | + Add to cart |
|
|
|
||||
Product description
UCI-1 (University of California, Irvine Coronavirus Inhibitor-1) is a first-in-class cyclic peptide that inhibits SARS-CoV main protease (Mpro, also known as 3CLpro). UCI-1 was developed by Professor James S. Nowick and designed to mimic the autolytic cleavage site of SARS-CoV Mpro.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Sequence | cyclo(-Phe-Gln-Ser-Lys-AEPA)/cyclo(-FQSK-AEPA) |
| Molecular Formula | C33H45N7O7 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of UCI-1
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


